AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $274,725 | +70.6% | 22,500 | +50.0% | 0.04% | +105.3% |
| Q2 2022 | $161,000 | -43.3% | 15,000 | -50.0% | 0.02% | +137.5% |
| Q1 2022 | $284,000 | -43.7% | 30,000 | -43.2% | 0.01% | -46.7% |
| Q3 2021 | $504,000 | +4.6% | 52,800 | +5.6% | 0.02% | -16.7% |
| Q2 2021 | $482,000 | -45.8% | 50,000 | -44.4% | 0.02% | -18.2% |
| Q1 2021 | $889,000 | -92.6% | 90,000 | -82.6% | 0.02% | -90.4% |
| Q4 2020 | $11,976,000 | +1198.9% | 518,700 | +694.3% | 0.23% | +570.6% |
| Q3 2020 | $922,000 | -67.8% | 65,300 | -65.6% | 0.03% | -82.8% |
| Q2 2020 | $2,865,000 | – | 190,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |